[Clinical studies on the broncholytic effect of NAB 365].
D000403:Airway Resistance / Q000187:drug effects; D000704:Analysis of Variance; D000814:Aniline Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001980:Bronchi / Q000187:drug effects*; D001991:Bronchitis / Q000188:drug therapy; D002245:Carbon Dioxide / Q000097:blood; D004983:Ethanolamines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005541:Forced Expiratory Volume; D006801:Humans; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D014797:Vital Capacity / Q000187:drug effects
D000814:Aniline Compounds; D004983:Ethanolamines; D002245:Carbon Dioxide; D009921:Metaproterenol; D010100:Oxygen
Klinsche Untersuchugen über die broncholytische Wirkung von NAB 365.